首页> 外国专利> COMPOSITION FOR REGENERATING CARTILAGE TISSUE OR INDUCING DIFFERENTIATION OF CHONDROCYTE WHILE INCLUDING EXOSOME ISOLATED FROM STEM CELL DERIVED FROM CORD BLOOD OR UMBILICAL CORD BEING DIFFERENTIATED INTO CHONDROCYTE

COMPOSITION FOR REGENERATING CARTILAGE TISSUE OR INDUCING DIFFERENTIATION OF CHONDROCYTE WHILE INCLUDING EXOSOME ISOLATED FROM STEM CELL DERIVED FROM CORD BLOOD OR UMBILICAL CORD BEING DIFFERENTIATED INTO CHONDROCYTE

机译:用于再生软骨组织或诱导软骨细胞分化的组合物,其中包括从脐带血或脐带血干细胞中分离出来的外显子,这些细胞被分化为软骨细胞

摘要

The present invention relates to a composition of regenerating cartilage tissues or inducing differentiation of chondrocytes while including exosomes isolated from stem cells derived from cord blood or umbilical cords being differentiated into the chondrocytes as an active ingredient, a medium composition for inducing the differentiation of chondrocytes including the composition, an injection agent for regenerating cartilage tissues, and a pharmaceutical composition for treating cartilage diseases. According to a specific embodiment of the present invention, the composition of regenerating cartilage tissues or inducing differentiation of chondrocytes includes the exosomes isolated from stem cells derived from cord blood or umbilical cords being differentiated into the chondrocytes as an effective factor. The exosomes secreted during the differentiation of stem cells contain growth factors related to the differentiation of chondrocytes as well as genes and proteins related to the proliferation and regeneration of stem cells, thereby having excellent properties related to regeneration of damaged cartilage tissues. The composition can accordingly minimize the side effects of an existing cell treatment agent and reliably and quickly transfer effective substances into the cells as a cell-derived carrier. The injection agent for treatment and prevention of cartilage diseases can reduce the pain of patients with a simple treatment operation and enable continuous and effective treatment of cartilage diseases after the treatment operation.;COPYRIGHT KIPO 2018
机译:本发明涉及再生软骨组织或诱导软骨细胞分化的组合物,同时包括将从脐带血或脐带血干细胞分离的外来体作为活性成分分化为软骨细胞的培养基组合物,其用于诱导软骨细胞分化的培养基组合物包括:该组合物,用于使软骨组织再生的注射剂和用于治疗软骨疾病的药物组合物。根据本发明的一个具体实施方案,再生软骨组织或诱导软骨细胞分化的组合物包括将从来源于脐带血或脐带的干细胞分离的外泌体作为有效因子分化成软骨细胞。在干细胞分化过程中分泌的外泌体包含与软骨细胞分化有关的生长因子,以及与干细胞增殖和再生有关的基因和蛋白质,从而具有与受损软骨组织再生有关的优异性能。因此,该组合物可以使现有细胞处理剂的副作用最小化,并且将有效物质作为细胞来源的载体可靠且快速地转移至细胞中。用于治疗和预防软骨疾病的注射剂可以通过简单的治疗操作减轻患者的痛苦,并在治疗后能够连续有效地治疗软骨疾病。; COPYRIGHT KIPO 2018

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号